Evidence map›Paper›PMID 39459042›Full record

ReviewPharmaceuticals (Basel, Switzerland)2024

Discovery and Development of Caffeic Acid Analogs as Versatile Therapeutic Agents.

Yi Mou, Shuai Wen, Hong-Kai Sha, Yao Zhao, Li-Juan Gui, Yan Wang, Zheng-Yu Jiang

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. ComparativeFoods (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Comprehensive Phytochemical and Biological Evaluation ofInternational journal of analytical chemistry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi MouCollege of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China.
Shuai WenCollege of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China.
Hong-Kai ShaCollege of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China.
Yao ZhaoCollege of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China.
Li-Juan GuiCollege of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China.
Yan WangCollege of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China.
Zheng-Yu JiangJiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.ORCID 0000-0002-1671-1582

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caffeic acid (CA) is a polyphenolic acid compound widely distributed in plant seeds. As natural compounds with high research interest, caffeic acid and its derivatives show good activity in the treatment of tumors and inflammation and have antibacterial properties. In recent years, caffeic acid derivatives have been studied extensively, and these derivatives fall roughly into three categories: (1) caffeic acid ester derivatives, (2) caffeic acid amide derivatives, (3) caffeic acid hybrids. These caffeic acid analogues exert mainly antibacterial and antioxidant activities. Among the caffeic acid analogues summarized in this paper, compounds

Indexed as

biological activitiescaffeic acidcaffeic acid derivativessynthesis methods

Identifiers

PMID39459042
PMCPMC11510674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.